Ellen Shrader
Impact in
-
- Ophthalmology and Eye Disorders
- Lymphoma Diagnosis and Treatment
-
- Acute Myeloid Leukemia Research
Papers in
-
- Histone Deacetylase Inhibitors Research 11
- Protein Degradation and Inhibitors 8
- Ubiquitin and proteasome pathways 2
-
- Acute Myeloid Leukemia Research 6
- Multiple Myeloma Research and Treatments 4
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Nathan S. Schlezinger (1 shared paper)Mary Beth Tombes (18 shared papers)Maciej Kmieciak (16 shared papers)Steven Grant (13 shared papers)Heidi Sankala (12 shared papers)Beata Holkova (12 shared papers)John D. Roberts (11 shared papers)Danielle Shafer (5 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (1 paper)Oncotarget (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- United States
In The Last Decade
Ellen Shrader
19 papers receiving 209 citations
Peers
Comparison fields: 5 of 47
- Pathology and Forensic Medicine 79
- Hematology 33
- Neurology 42
- Genetics 21
- Dermatology 15
Countries citing papers authored by Ellen Shrader
This map shows the geographic impact of Ellen Shrader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Shrader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Shrader more than expected).
Fields of papers citing papers by Ellen Shrader
This network shows the impact of papers produced by Ellen Shrader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Shrader. The network helps show where Ellen Shrader may publish in the future.
Co-authors
The 25 scholars most cited alongside Ellen Shrader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1960 | 62 | |
| 2 | 2013 | 26 | |
| 3 | 2017 | 21 | |
| 4 | 2015 | 17 | |
| 5 | 2020 | 16 | |
| 6 | 2023 | 14 | |
| 7 | 2011 | 9 | |
| 8 | 2014 | 9 | |
| 9 | 2020 | 9 | |
| 10 | 2016 | 8 | |
| 11 | 2012 | 6 | |
| 12 | 2012 | 4 | |
| 13 | 2020 | 4 | |
| 14 | 2013 | 4 | |
| 15 | 2011 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2017 | 2 | |
| 18 | 2011 | 2 | |
| 19 | 2012 | 1 |
About Ellen Shrader
Ellen Shrader is a scholar working on Molecular Biology, Hematology, Genetics, Pulmonary and Respiratory Medicine and Oncology, having authored 19 papers that have together received 219 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (11 papers), Protein Degradation and Inhibitors (8 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Ubiquitin and proteasome pathways (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (79 citations), Hematology (33 citations), Neurology (42 citations), Genetics (21 citations) and Dermatology (15 citations). Ellen Shrader has collaborated with scholars based in United States. Frequent co-authors include Nathan S. Schlezinger, Mary Beth Tombes, Maciej Kmieciak, Steven Grant, Heidi Sankala, Beata Holkova, John D. Roberts, Danielle Shafer, Wen Wan and Prithviraj Bose. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, Oncotarget and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.